SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "LAR1:uu ;mspu:(patent)"

Sökning: LAR1:uu > Patent

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Aahlin, Kristofer, et al. (författare)
  • Preparation of 1-(4-(5-amino-6-(oxazolo[4,5-c]pyridin-2-yl)pyrazin-2-yl)benzoyl)piperazine derivatives as glycogen synthase kinase 3 inhibitors.
  • 2011
  • Patent (populärvet., debatt m.m.)abstract
    • Title compds. I [R1 = H or Me], and their pharmaceutically acceptable salts, are prepd. and disclosed as glycogen synthase kinase 3 (GSK3) inhibitors. Thus, e.g., II was prepd. by cyclization of 3-amino-N-(4-hydroxypyridin-3-yl)pyrazine-2-carboxamide (prepn. given) to get intermediate 3-(oxazolo[4,5-c]pyridin-2-yl)pyrazin-2-amine, which underwent bromination followed by Suzuki reaction with (4-methylpiperazin-1-yl)(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone. Compds. of the invention were tested for their selective inhibitory activity of GSK3β, e.g., II exhibited Ki value of 2.3 nM. The invention compds. are useful for the treatment of cognitive disorders, diabetes, cancer, etc. [on SciFinder(R)]
  •  
2.
  • Ahnesjö, Anders, et al. (författare)
  • Detector response modeling
  • 2009
  • Patent (populärvet., debatt m.m.)abstract
    • A detector response correction arrangement and method is proposed for online determination of correction factors for arbitrary positions from arbitrary incident fluence distributions. As modern radiotherapy utilizes more of the available degrees of freedom of radiation machines, dosimetry has to be able to present reliable measurements for all these degrees of freedom. To determine correction factors online during measurement, Monte Carlo technique is used to precalculate fluence pencil kernels from a monodirectional beam to fully describe the particle fluence in an irradiated medium. Assuming that the particle fluence is not significantly altered by the introduction of a small detector volume, the fluence pencil kernels (212) can be integrated (214), and correction factors (216) determined, e.g. by Cavity Theory, in different positions for the detector material.
  •  
3.
  • Antonov, D, et al. (författare)
  • HCV inhibiting macrocyclic phenylcarbamates
  • 2008
  • Patent (populärvet., debatt m.m.)abstract
    • Compounds of the formula I: including a stereoisomer thereof, or an N-oxide, a pharmaceutically acceptable addition salt, or a pharmaceutically acceptable addition solvate thereof; useful as HCV inhibitors; processes for preparing these compounds as well as pharmaceutical compositions comprising these compounds as active ingredient.
  •  
4.
  • Arvidsson, Per I., et al. (författare)
  • Preparation of imidazolylpyrimidine derivatives for treatment of glycogen synthase kinase 3 related disorders such as Alzheimer's disease.
  • 2010
  • Patent (populärvet., debatt m.m.)abstract
    • Title compds. I [R1 = H or F; R2 and R3 independently = H or Me], and their pharmaceutically acceptable salts, are prepd. and disclosed as agents for treatment of glycogen synthase kinase 3 (GSK3) related disorders such as Alzheimer's disease. Thus, e.g., II.HCl was prepd. by reductive amination of 4-bromo-3-fluorobenzaldehyde with (S)-3-methylmorpholine followed by amination with 2-amino-5-fluoro-4-(2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazol-5-yl)pyrimidine. Select I were evaluated for GSK3β inhibitory activity, and e.g., II·HCl demonstrated a Ki value of 30 nM. [on SciFinder(R)]
  •  
5.
  • Arvidsson, Per, et al. (författare)
  • Preparation of arylimidazopyridine derivatives for use as GSK3 modulators.
  • 2008
  • Patent (populärvet., debatt m.m.)abstract
    • Title compds. I [A = (un)substituted aryl or heteroaryl; Q = halo; R1 = C(O)NR6R7; R2 and R4 independently = H, halo, CN, NO2, alkyl, or haloalkyl; R3 and R5 independently = H, halo, alkyl, or haloalkyl; R6 and R7 = together with the atoms to which they are attached form an (un)substituted heterocyclic ring contg. one or more heteroatoms selected from N, O, or S;], and their pharmaceutically acceptable salts, are prepd. and disclosed as glycogen synthase kinase-3 (GSK3) modulators. Thus, e.g., II•HCl was prepd. by cyclocondensation of 5-bromopyridine-2,3-diamine with terephthalic monomethyl ester followed by chlorination, iodination, sapon., amidation with N-methylpiperazine, and coupling with 4-methoxyphenyl boronic acid. I were evaluated in GSK3β scintillation proximity assays, e.g., II•HCl demonstrated an Ki value of 97 nM. [on SciFinder(R)]
  •  
6.
  • Arvidsson, Per, et al. (författare)
  • Preparation of imidazopyridinecarboxamide derivatives for use as GSK3 modulators.
  • 2008
  • Patent (populärvet., debatt m.m.)abstract
    • Title compds. I [Q = halo; R1 = CH2NR3R4; each R2 independently = H or alkyl; R3 and R4 = together with the atoms to which they are attached form an (un)substituted heterocyclic ring contg. one or more heteroatoms selected from N, O, or S; R6 = H or alkyl; R7 = H, (un)substituted alkyl, alkylaryl, aryl, or heteroaryl], and their pharmaceutically acceptable salts, are prepd. and disclosed as glycogen synthase kinase-3 (GSK3) modulators. Thus, e.g., II•HCl was prepd. by cyclocondensation of 5-bromopyridine-2,3-diamine with terephthalic monomethyl ester followed by chlorination, iodination, sapon., amidation with morpholine, redn., and coupling with carbon monoxide and 3-methoxy-1-propanamine. I were evaluated in GSK3β scintillation proximity assays, e.g., II•HCl demonstrated an Ki value of 390 nM. [on SciFinder(R)]
  •  
7.
  • Ayesa, S., et al. (författare)
  • CYSTEINE PROTEASE INHIBITORS
  • 2011
  • Patent (populärvet., debatt m.m.)abstract
    • Compounds of the formula IwhereinR1a is H; and R1b is C1-C6 alkyl, Carbocyclyl or Het; orR1a and R1b together define a saturated cyclic amine with 3-6 ring atoms;R2a and R2b are H, halo, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy; orR2a and R2b together with the carbon atom to which they are attached form a C3-C6cycloalkyl;R3 is a branched C5-C10alkyl chain, C2-C4haloalkyl or C3-C7cycloalkylmethyl,R4 is Het, Carbocyclyl,optionally substituted as defined in the specification and pharmaceutically acceptable salts,hydrates and N-oxides thereof; are inhibitors of cathepsin S and have utility in the treatment of psoriasis, autoimmune disorders and other disorders such as asthma, arteriosclerosis, COPD and chronic pain.
  •  
8.
  •  
9.
  •  
10.
  • Azens, A., Vaivars, G., Veszelei, M., Granqvist, C-G. Azens, A., Vaivars, G., Veszelei, M., Granqvist, C-G. Azens, A., Vaivars, G., Veszelei, M., Granqvist, C-G. (författare)
  • 6-layer electrochromic device.
  • 2001
  • Patent (övrigt vetenskapligt)
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (2)
Typ av publikation
Typ av innehåll
populärvet., debatt m.m. (278)
övrigt vetenskapligt (6)
Författare/redaktör
Hagersten, Erik (45)
Zhen, Zhang, 1979-, (42)
Engqvist, Håkan, (22)
Strömme, Maria, 1970 ... (20)
Xia, Wei, (18)
Strømme, Maria, (11)
visa fler...
Lavoie, C. (11)
Mihranyan, Albert, 1 ... (11)
Caldwell, K. D., (9)
Yang, B (8)
Schaal, Wesley, PhD, (8)
Granqvist, C. G. (8)
Pelcman, Benjamin (8)
Olofsson, Kristofer (8)
Yngve, Ulrika. (7)
Jansson, Ulf, (7)
Nyholm, Leif, (6)
Ozcan, A. (6)
Zhang, Z., (5)
Svedlindh, Peter (5)
Strömberg, Mattias, (5)
Gunnarsson, Klas, (5)
Wilhelmsson, Ola, (5)
Edvinsson, Tomas, (5)
Risch, Tore, (5)
Mihranyan, Albert, (5)
Huang, S.C., (5)
Herron, J.N., (5)
Christensen, D.A. (5)
Wang, H.K. (5)
Hagfeldt, Anders (4)
Österlund, Lars, (4)
Nilsson, Mats, (4)
Bergström, Jan, (4)
Lewin, Erik, 1979-, (4)
Tian, Haining, (4)
Garcia-Bennett, Alfo ... (4)
Söderberg, Lennart, (4)
Azens, A, (4)
Göransson, Jenny (4)
Yngve, Ulrika, 1972- (4)
Erk, Peter (4)
Yang, Xichuan, (4)
Khater, M (4)
Eickemeyer, Felix (4)
Schoeneboom, Jan (4)
Li, Chen (4)
Herrmann, Andreas (4)
Muellen, Klaus (4)
Engman, Lars, 1952-, (4)
visa färre...
Lärosäte
Uppsala universitet (284)
Kungliga Tekniska Högskolan (1)
Språk
Engelska (276)
Kinesiska (2)
Svenska (1)
Tyska (1)
Franska (1)
Ryska (1)
visa fler...
Japanska (1)
Koreanska (1)
visa färre...
Forskningsämne (UKÄ/SCB)
Teknik (163)
Naturvetenskap (37)
Medicin och hälsovetenskap (24)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy